Kestra Advisory Services’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,903
| Closed | -$286K | – | 2843 |
|
|
2025
Q1 | $286K | Sell |
1,903
-405
| -18% | -$61K | ﹤0.01% | 2195 |
|
|
2024
Q4 | $426K | Sell |
2,308
-893
| -28% | -$165K | ﹤0.01% | 1972 |
|
|
2024
Q3 | $631K | Sell |
3,201
-17
| -0.5% | -$3.35K | ﹤0.01% | 1616 |
|
|
2024
Q2 | $665K | Buy |
3,218
+12
| +0.4% | +$2.48K | ﹤0.01% | 1588 |
|
|
2024
Q1 | $869K | Buy |
3,206
+224
| +8% | +$60.7K | 0.01% | 1325 |
|
|
2023
Q4 | $705K | Buy |
2,982
+304
| +11% | +$71.9K | 0.01% | 1319 |
|
|
2023
Q3 | $525K | Buy |
2,678
+48
| +2% | +$9.41K | 0.01% | 1347 |
|
|
2023
Q2 | $553K | Sell |
2,630
-188
| -7% | -$39.5K | 0.01% | 1277 |
|
|
2023
Q1 | $569K | Sell |
2,818
-5,955
| -68% | -$1.2M | 0.01% | 1211 |
|
|
2022
Q4 | $1.91M | Buy |
8,773
+800
| +10% | +$174K | 0.02% | 768 |
|
|
2022
Q3 | $1.57M | Sell |
7,973
-405
| -5% | -$79.7K | 0.02% | 762 |
|
|
2022
Q2 | $1.79M | Buy |
8,378
+1,194
| +17% | +$256K | 0.02% | 715 |
|
|
2022
Q1 | $2.04M | Buy |
7,184
+1,096
| +18% | +$311K | 0.02% | 669 |
|
|
2021
Q4 | $2.29M | Buy |
6,088
+1,723
| +39% | +$649K | 0.02% | 637 |
|
|
2021
Q3 | $1.8M | Buy |
4,365
+157
| +4% | +$64.8K | 0.02% | 759 |
|
|
2021
Q2 | $1.56M | Sell |
4,208
-624
| -13% | -$231K | 0.02% | 749 |
|
|
2021
Q1 | $1.4M | Buy |
4,832
+3,832
| +383% | +$1.11M | 0.02% | 733 |
|
|
2020
Q4 | $249K | Buy |
+1,000
| New | +$249K | ﹤0.01% | 1574 |
|